Global Gastrointestinal Stromal Tumors Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	165 Pages	TechNavio	December, 2023	INF18413886

Best Price Guarantee
Price	from $2,500
Length	165 Pages
Publisher	TechNavio
Published Date	December, 2023
SKU	INF18413886

Global Gastrointestinal Stromal Tumors Therapeutics Market 2024-2028

The gastrointestinal stromal tumors therapeutics market is forecasted to grow by USD 1.02 bn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the gastrointestinal stromal tumors therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, growing adoption of gist therapeutics, and increasing awareness campaigns about gist.

Technavio's gastrointestinal stromal tumors therapeutics market is segmented as below:

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Oral
Parenteral

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of regenerative therapy for gist as one of the prime reasons driving the gastrointestinal stromal tumors therapeutics market growth during the next few years. Also, strong pipeline for gist therapeutics and increasing research funding for gist therapeutics will lead to sizable demand in the market.

The report on the gastrointestinal stromal tumors therapeutics market covers the following areas:

Gastrointestinal stromal tumors therapeutics market sizing
Gastrointestinal stromal tumors therapeutics market forecast
Gastrointestinal stromal tumors therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal stromal tumors therapeutics market vendors that include Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., Bristol Myers Squibb Co., Deciphera Pharmaceuticals Inc, Mendus AB, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Xencor Inc., AB Science SA, AROG Pharmaceuticals INC., Ipsen Pharma, Theseus Pharmaceuticals., Daiichi Sankyo Co. Ltd., Merck KGaA, and Takeda Pharmaceutical Co. Ltd.. Also, the gastrointestinal stromal tumors therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global gastrointestinal stromal tumors therapeutics market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion); 4.2 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Route of Administration Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Exhibit 32: Chart on Comparison by Distribution Channel; Exhibit 33: Data Table on Comparison by Distribution Channel; 6.3 Hospital pharmacies - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); 6.4 Retail pharmacies - Market size and forecast 2023-2028; Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); 6.5 Online pharmacies - Market size and forecast 2023-2028; Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Distribution Channel; Exhibit 46: Market opportunity by Distribution Channel ($ billion); Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Route of Administration: 7.1 Market segments; Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%); Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%); 7.2 Comparison by Route of Administration; Exhibit 50: Chart on Comparison by Route of Administration; Exhibit 51: Data Table on Comparison by Route of Administration; 7.3 Oral - Market size and forecast 2023-2028; Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%); 7.4 Parenteral - Market size and forecast 2023-2028; Exhibit 56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on Parenteral - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Route of Administration; Exhibit 60: Market opportunity by Route of Administration ($ billion); Exhibit 61: Data Table on Market opportunity by Route of Administration ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 France - Market size and forecast 2023-2028; Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ billion); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion); 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends; 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business; 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 AB Science SA; Exhibit 111: AB Science SA - Overview; Exhibit 112: AB Science SA - Product / Service; Exhibit 113: AB Science SA - Key offerings; 12.4 AROG Pharmaceuticals INC.; Exhibit 114: AROG Pharmaceuticals INC. - Overview; Exhibit 115: AROG Pharmaceuticals INC. - Product / Service; Exhibit 116: AROG Pharmaceuticals INC. - Key offerings; 12.5 Ascentage Pharma; Exhibit 117: Ascentage Pharma - Overview; Exhibit 118: Ascentage Pharma - Product / Service; Exhibit 119: Ascentage Pharma - Key offerings; 12.6 Bayer AG; Exhibit 120: Bayer AG - Overview; Exhibit 121: Bayer AG - Business segments; Exhibit 122: Bayer AG - Key news; Exhibit 123: Bayer AG - Key offerings; Exhibit 124: Bayer AG - Segment focus; 12.7 Blueprint Medicines Corp.; Exhibit 125: Blueprint Medicines Corp. - Overview; Exhibit 126: Blueprint Medicines Corp. - Product / Service; Exhibit 127: Blueprint Medicines Corp. - Key news; Exhibit 128: Blueprint Medicines Corp. - Key offerings; 12.8 Bristol Myers Squibb Co.; Exhibit 129: Bristol Myers Squibb Co. - Overview; Exhibit 130: Bristol Myers Squibb Co. - Product / Service; Exhibit 131: Bristol Myers Squibb Co. - Key news; Exhibit 132: Bristol Myers Squibb Co. - Key offerings; 12.9 Daiichi Sankyo Co. Ltd.; Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview; Exhibit 134: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news; Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings; 12.10 Deciphera Pharmaceuticals Inc; Exhibit 137: Deciphera Pharmaceuticals Inc - Overview; Exhibit 138: Deciphera Pharmaceuticals Inc - Business segments; Exhibit 139: Deciphera Pharmaceuticals Inc - Key news; Exhibit 140: Deciphera Pharmaceuticals Inc - Key offerings; Exhibit 141: Deciphera Pharmaceuticals Inc - Segment focus; 12.11 Ipsen Pharma; Exhibit 142: Ipsen Pharma - Overview; Exhibit 143: Ipsen Pharma - Business segments; Exhibit 144: Ipsen Pharma - Key offerings; Exhibit 145: Ipsen Pharma - Segment focus; 12.12 Mendus AB; Exhibit 146: Mendus AB - Overview; Exhibit 147: Mendus AB - Product / Service; Exhibit 148: Mendus AB - Key offerings; 12.13 Novartis AG; Exhibit 149: Novartis AG - Overview; Exhibit 150: Novartis AG - Business segments; Exhibit 151: Novartis AG - Key offerings; Exhibit 152: Novartis AG - Segment focus; 12.14 Pfizer Inc.; Exhibit 153: Pfizer Inc. - Overview; Exhibit 154: Pfizer Inc. - Product / Service; Exhibit 155: Pfizer Inc. - Key news; Exhibit 156: Pfizer Inc. - Key offerings; 12.15 Sun Pharmaceutical Industries Ltd.; Exhibit 157: Sun Pharmaceutical Industries Ltd. - Overview; Exhibit 158: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibit 159: Sun Pharmaceutical Industries Ltd. - Key offerings; 12.16 Theseus Pharmaceuticals.; Exhibit 160: Theseus Pharmaceuticals. - Overview; Exhibit 161: Theseus Pharmaceuticals. - Product / Service; Exhibit 162: Theseus Pharmaceuticals. - Key offerings; 12.17 Xencor Inc.; Exhibit 163: Xencor Inc. - Overview; Exhibit 164: Xencor Inc. - Product / Service; Exhibit 165: Xencor Inc. - Key news; Exhibit 166: Xencor Inc. - Key offerings; 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 167: Inclusions checklist; Exhibit 168: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 169: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 170: Research methodology; Exhibit 171: Validation techniques employed for market sizing; Exhibit 172: Information sources; 13.5 List of abbreviations; Exhibit 173: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Distribution Channel; Exhibits33: Data Table on Comparison by Distribution Channel; Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Distribution Channel ($ billion); Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits48: Chart on Route of Administration - Market share 2023-2028 (%); Exhibits49: Data Table on Route of Administration - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Route of Administration; Exhibits51: Data Table on Comparison by Route of Administration; Exhibits52: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on Parenteral - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%); Exhibits60: Market opportunity by Route of Administration ($ billion); Exhibits61: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits103: Market opportunity By Geographical Landscape ($ billion); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits105: Impact of drivers and challenges in 2023 and 2028; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: AB Science SA - Overview; Exhibits112: AB Science SA - Product / Service; Exhibits113: AB Science SA - Key offerings; Exhibits114: AROG Pharmaceuticals INC. - Overview; Exhibits115: AROG Pharmaceuticals INC. - Product / Service; Exhibits116: AROG Pharmaceuticals INC. - Key offerings; Exhibits117: Ascentage Pharma - Overview; Exhibits118: Ascentage Pharma - Product / Service; Exhibits119: Ascentage Pharma - Key offerings; Exhibits120: Bayer AG - Overview; Exhibits121: Bayer AG - Business segments; Exhibits122: Bayer AG - Key news; Exhibits123: Bayer AG - Key offerings; Exhibits124: Bayer AG - Segment focus; Exhibits125: Blueprint Medicines Corp. - Overview; Exhibits126: Blueprint Medicines Corp. - Product / Service; Exhibits127: Blueprint Medicines Corp. - Key news; Exhibits128: Blueprint Medicines Corp. - Key offerings; Exhibits129: Bristol Myers Squibb Co. - Overview; Exhibits130: Bristol Myers Squibb Co. - Product / Service; Exhibits131: Bristol Myers Squibb Co. - Key news; Exhibits132: Bristol Myers Squibb Co. - Key offerings; Exhibits133: Daiichi Sankyo Co. Ltd. - Overview; Exhibits134: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits135: Daiichi Sankyo Co. Ltd. - Key news; Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits137: Deciphera Pharmaceuticals Inc - Overview; Exhibits138: Deciphera Pharmaceuticals Inc - Business segments; Exhibits139: Deciphera Pharmaceuticals Inc - Key news; Exhibits140: Deciphera Pharmaceuticals Inc - Key offerings; Exhibits141: Deciphera Pharmaceuticals Inc - Segment focus; Exhibits142: Ipsen Pharma - Overview; Exhibits143: Ipsen Pharma - Business segments; Exhibits144: Ipsen Pharma - Key offerings; Exhibits145: Ipsen Pharma - Segment focus; Exhibits146: Mendus AB - Overview; Exhibits147: Mendus AB - Product / Service; Exhibits148: Mendus AB - Key offerings; Exhibits149: Novartis AG - Overview; Exhibits150: Novartis AG - Business segments; Exhibits151: Novartis AG - Key offerings; Exhibits152: Novartis AG - Segment focus; Exhibits153: Pfizer Inc. - Overview; Exhibits154: Pfizer Inc. - Product / Service; Exhibits155: Pfizer Inc. - Key news; Exhibits156: Pfizer Inc. - Key offerings; Exhibits157: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits158: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits159: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits160: Theseus Pharmaceuticals. - Overview; Exhibits161: Theseus Pharmaceuticals. - Product / Service; Exhibits162: Theseus Pharmaceuticals. - Key offerings; Exhibits163: Xencor Inc. - Overview; Exhibits164: Xencor Inc. - Product / Service; Exhibits165: Xencor Inc. - Key news; Exhibits166: Xencor Inc. - Key offerings; Exhibits167: Inclusions checklist; Exhibits168: Exclusions checklist; Exhibits169: Currency conversion rates for US$; Exhibits170: Research methodology; Exhibits171: Validation techniques employed for market sizing; Exhibits172: Information sources; Exhibits173: List of abbreviations